November 16, 2023

CEO Malcolm McColl speaks at Bell Potter Healthcare Conference

ImmVirX is pleased to advise that Co-Founder and CEO Dr Malcolm McColl’s presentation at the Bell Potter Healthcare Conference 2023 held in November is available to view here.

Day: November 16, 2023

CEO Malcolm McColl speaks at Bell Potter Healthcare Conference

Join Our Mailing List

Our mission is to develop receptor-targeted oncolytic RNA immunotherapies that improve outcomes for patients with cancers that are difficult to treat

Company